Berlin, June 27, 2017 – Medios AG, an expert pharmaceutical partner and solution provider in the specialty pharma segment, appoints Mi-Young Miehler as Chief Operating Officer (COO), effective July 1, 2017. The supervisory board decided this today. Ms. Miehler will manage Medios AG’s business operations and continue her work as managing director of the subsidiaries Medios Pharma GmbH and Medios Digital GmbH. Her appointment means that she will join Manfred Schneider (Chief Executive Officer, CEO) and Matthias Gärtner (Chief Financial Officer, CFO) as the third member of the management board.
Yann Samson, the chairman of the supervisory board of Medios AG, comments: “With Mi-Young Miehler, we are pleased to appoint an experienced businesswoman to the management board of Medios AG. As manager of our fast-growing subsidiaries, Medios Pharma and Medios Digital, she has excellent know-how – both in the area of wholesale specialty pharmaceuticals and in the digitalization of the business. She thereby brings two important types of expertise to the supervisory team.”
Ms. Miehler (48) studied business administration at the Berufsakademie (Vocational University) in Ravensburg, and Korean at Eberhard Karls University in Tübingen and at the University of London. She began her career as a strategy and marketing consultant at Schott Glas in Mainz. She next worked for Scholz & Friends Agenda GmbH in Berlin. Since 2009, she has focused on the specialty pharma market and has held management positions at Medios AG’s various predecessor companies.
Mi-Young Miehler, future COO of Medios AG, comments: “I would like to thank the supervisory board for the trust it has placed in me and for putting me in charge of business operations. I look forward to my new task. With the growing importance of specialty pharmaceuticals in the healthcare sector, the challenges faced by specialty pharma companies are also increasing. At Medios, we cover all important segments of the supply chain – and therefore are very likely to benefit from this development.”
Medios is one of the leading competency partners and solutions providers for specialty pharmaceuticals in Germany. These are medicines for patients with rare or chronic diseases such as cancer, HIV and hepatitis, whose personalized therapy is often tedious and cost-intensive due to their individual requirements.
With our subsidiaries Medios Pharma, Medios Manufaktur and Medios Digital we connect individual market players to form cooperating partners. Our goal is to provide partners and customers with integrated solutions along the value chain, ensuring optimal patient care.
Kirchhoff Consult AG
Phone: +49 40 60918618
Fax: +49 40 60918660
This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future results may significantly deviate from currently expected results, specifically due to various risk factors and uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no responsibility whatsoever for updating the forward-looking statements contained in this notification.